I lost 18st without fat jabs – I didn't cheat my way to a new body by secretly using Ozempic, I put the effort in
NO WEIGH I lost 18st without fat jabs – I didn't cheat my way to a new body by secretly using Ozempic, I put the effort in
OPENING my 10th can of cola of the day and gorging on a Chinese takeaway, I felt utterly miserable.
Weighing 29st and a size 32, I was practically housebound and struggling to care for my children. It was a conversation with my husband in early 2023 that would shock me into finally losing weight, after years of it spiralling out of control.
5
At 10st 13lb, Kate's happier and healthier after losing 18st without using weight loss injections
5
Kate with husband Dan at her heaviest weight of 29st
Today, I'm more than 18st lighter, but to my frustration, there are people who don't believe I lost the weight through diet and exercise.
They accuse me of secretly using fat jabs and say I cheated my way to a new body.
When my husband Dan told me that day that he was scared I was going to die, I knew his fears were justified. At 38, I was pre-diabetic and could barely walk, with aching joints and breathlessness. I agreed to join a slimming club, but had no idea how I'd lose the excess weight.
All my life, I've been big. At 10, I weighed 9st, the weight of an adult woman, because I had a big appetite.
BIG APPETITE
As a teenager, when I had more independence and money to spend, I'd buy crisps, chocolate and fizzy drinks. I did try a few times to lose weight in my 20s, but always gave up and put it back on, and more.
When I met Dan online in 2013, after having my first child in a previous relationship, I was a size 24. He didn't care, though, and saw past my weight. He loved me as I was, and we got married in 2016.
I treated food like an emotional crutch. No matter how I was feeling, I turned to it. I look back with horror at what I'd consume daily – litres of fizzy drink, greasy takeaways, piles of buttered toast and chocolate.
By the time Dan had that emotional conversation with me, I was only leaving the house once a week to go to the supermarket, and I slept downstairs because getting up to our bedroom was too hard for me.
'No shortcuts exist' I'm an Irish teen who lost almost 60 pounds in 16 weeks following a routine that works wonders
He had to take on more than his share, and I could never take the kids to the park or on a day trip. Had Dan not confided his fears in me, I'm not sure if I'd have ever given myself that push to lose weight.
Stepping on to the scales at my first slimming club meeting in February 2023, I felt mortified. At 29st 4.5lb, I was by far the biggest person there. But for Dan and my children's sake, I knew I needed to try.
So, using the club's plan as a starting point, I began learning about nutrition. I started having fruit and yoghurt for breakfast, a wrap with salad for lunch, and chicken with veg for dinner. I stopped having takeaways and gradually weaned myself off sugary drinks.
Attending a weekly meeting and being weighed kept me accountable, and as I started to see the number on the scales go down, I felt motivated to keep going. I began to introduce walking, too.
At first, even short distances left me with sore joints and out of breath, but I persevered and it became more enjoyable.
5
Kate ended up practically housebound and struggling to care for her children due to her weight
5
Kate lost the weight to be a better mum
5
Kate's husband Dan was scared she was going to die because of the excess weight
Dan was so supportive and relieved I was taking care of myself. By April 2024, I'd lost 17st. I decided to keep going and now weigh 10st 13lb. I don't plan to lose any more, but still attend my weekly club meetings.
It's surreal when I walk into a clothes shop and can pick out size-12 dresses. People I haven't seen in a while have walked past, not recognising me, and there was even a rumour in our area Dan was having an affair, because he was spotted with another woman. But that was me!
What frustrates me is, after all the effort I've put in, I've been accused of secretly using weight-loss jabs. I've seen it happen online to celebrities, such as TV presenter Alison Hammond, who's lost 11st without jabs, too.
Personally, I think it's cheating to use them to lose weight. I put the pounds on and it was up to me to lose them, not rely on pharmaceuticals.
When I look back at old photos, I don't recognise that unhealthy, unhappy woman.
I've saved my life and am the active, happy wife and mum I always dreamed of being. And I did it all by myself.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
2 hours ago
- Scottish Sun
First ever daily Ozempic-like PILL helps users shed up to 2st – and could be available within months
Manufacturer Lilly said the first-of-its-kind pill could be launched "at scale" worldwide as early as next year WEIGHT OFF First ever daily Ozempic-like PILL helps users shed up to 2st – and could be available within months Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A DAILY weight loss pill that works like Ozempic can help users shed an average of almost two stone, a study reveals. People popping the slimming pills lost an average of 12.4 per cent of their body weight after 72 weeks in a groundbreaking final-stage trial. Sign up for Scottish Sun newsletter Sign up 2 Slimming pills could be available as early as next year Credit: Getty Bad cholesterol, blood fats and high blood pressure also dropped and stayed low, suggesting the one-a-day tablets could treat other conditions. Manufacturer Eli Lilly and Company, which also makes the blockbuster weight loss injection Mounjaro, announced the highly anticipated results today. Dr Kenneth Custer, Lily's president, said: "We're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments." The weight loss achieved with orforglipron appears comparable to, though slightly lower than, that seen with Novo Nordisk's weekly obesity jab, Wegovy. Manufacturer Lilly said the first-of-its-kind pill could be launched "at scale" worldwide as early as next year. It now plans to apply for regulatory approval within months. Orforglipron is a drug known as a GLP-1 receptor agonist, the same as wildly popular jabs Ozempic, Mounjaro and Wegovy. They work by mimicking hormones that tell the brain the stomach is full, releasing insulin to break down sugar in the blood. This also switches off hunger signals, so the patient eats less and avoids weight gain. Sun Health Explainer: Fat jabs Lily's 72-week study involved 3,127 adults who were obese or were overweight and had a weight-related medical problem. Participants were given either a fake pill or one of three possible doses of orforglipron. All three doses delivered "clinically meaningful weight loss". A 36mg dose - the highest dose - led to 12.4 per cent weight loss, over the course of the study, known as ATTAIN-1. People taking a fake tablet lost 0.9 per cent. The popularity of GLP-1 slimming injections has rocketed in the past two years because they cause such easy, rapid weight loss. 2 Around a third of adults in the UK are obese and the rate has doubled since the 1990s. But the side effects can be severe, and the jabs can also be expensive - usually costing between £100 - £300 per month. Lilly has not yet decided how much the pills will cost. But it is expected they will be cheaper than their jab counterparts as the pills are easier and cheaper to produce. Orforglipron is also easier to use as it can be stored at room temperature and taken at any time of day. Side effects on the tablet were similar to the weight-loss injections. Nausea was the most common side effect in the trial, affecting up to one in three people, with some also getting constipation and/or diahorrea. Dr Kenneth, said: "With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need." Dr Simon Cork, Senior Lecturer in Physiology, Anglia Ruskin University, added: 'These early results on the effectiveness of orforglipron in promoting clinically significant weight loss are a positive step forward in the development of these class of drugs. 'It should be noted that their effects on weight loss are not as profound as that seen in injectable GLP-1 receptor agonists, such as Wegovy, with a lower percentage weight loss and fewer people achieving 10 per cent weight loss at the highest dose. 'Nevertheless, that this medication is an oral form, rather than injectable, will likely be seen as more tolerable for many patients. "The manufacturing costs are also anticipated to be significantly lower than injectable drugs, meaning these medications may be more equitable in their availability. 'It should be noted that these are preliminary, non-peer reviewed results and we will need to see the full trial methodology and data before a more comprehensive analysis can be undertaken.'
Daily Mail
4 hours ago
- Daily Mail
Maura Higgins, 34, poses for a mirror selfie in a red hospital gown before an MRI as her mystery injury is revealed
revealed she had an MRI on Thursday as she posed for a mirror selfie wearing a red hospital gown on Instagram. The Love Island star, 34, left her long brunette tresses loose as she hid her face behind her phone for the snap taken in the hospital changing rooms. She wrote: 'MRI ready'. While she didn't give any more information alongside the post, Maura recently revealed that her knee has been 'killing her' as she opened up about about the injury with her 4million followers. The Irish model explained that she can 'feel a pulse' inside her knee and due to 'running around' while moving house the pain has got worse. Posing in a make-up free selfie as she held a drink in her hand, she wrote: 'Don't have the time right now to see a specialist, but if anyone has any recommendations for something I can buy to stop my knee from KILLING please DM me. While she didn't give any more information alongside the post, Maura recently revealed that her knee has been 'killing her' as she opened up about about the injury with her 4million followers 'It feels like there's a pulse inside of it & it's also on fire. 'The running around with the house move has not helped it. (yes my greys are out too, no time for that either.' Maura will have to wait and see the results of the MRI before she will know exactly what is causing her knee pain. According to the NHS, an MRI (Magnetic Resonance Imaging) is a medical imaging technique that uses strong magnetic fields and radio waves to create detailed pictures of the inside of the body. It is a non-invasive and painless procedure used to diagnose and monitor various medical conditions. The concerning update comes after Maura moved into her £1.25million five-bedroom 'dream house' in Essex. Maura, who has amassed an estimated £3.2million fortune from her TV appearances, took to Instagram earlier this month to share the news that she had finally moved in. Sharing the news she posted a picture of stunning black French doors looking on to a garden, with a huge bouquet of glowers in a vase, Ferrari sparkling wine and a Diptyque candle. 'After the busiest few months.... she's finally in,' the former Love Island star captioned the snap. Sharing another snap of the kitchen featuring her pal, celebrity hairdresser Carl Bembridge, she wrote: 'No chairs yet but he always finds something to sit on.' As a young woman in rural Ireland, Maura's future was set - stay in the town, marry her teenage boyfriend and open up a hair salon. 'But that's not what I wanted. That was not my dream. That was my father's and boyfriend's dream. I wanted to do more,' Maura previously defiantly declared. And leave Ireland she did, going on to star in two ITV reality shows, Love Island and most recently I'm A Celebrity, as well as taking on presenting duties. In her next big move, the girl from remote County Longford purchased her huge house in Essex. Her riches have allowed the presenter to upgrade from her previous one-bedroom property in Essex to one with an en-suite master bedroom with four further rooms. Overjoyed, Maura shared to her Instagram followers a picture of her new kitchen with a chandelier and grey floors, which she bought in October, with the caption 'Bought my dream house'. An expansive kitchen, with an island, leads out past the dining area, out bi-folding doors to a large walled garden with a neat lawn. Maura's previous home was raided by three-masked men and so the Love Island star has ensured her new home was in a gated development which provides privacy and security.
Daily Mail
5 hours ago
- Daily Mail
Daily weight loss pill that works like Ozempic helped users lose an average of almost TWO STONES in groundbreaking trial
A daily weight loss pill that works like breakthrough fat jab Ozempic can help users lose an average of almost two stones (12.4kg), a study reveals. People taking the new wonder drug orforglipron lost an average of 12.4 per cent of their body weight after 72 weeks in a groundbreaking final stage trial. The participants, who were overweight but did not have diabetes, also benefited from reductions in bad cholesterol, blood fats and blood pressure. Manufacturer Lilly said the once-a-day pill - the first of its kind - could be launched 'at scale' worldwide and 'without supply constraints' as early as next year. It now plans to apply for regulatory approval within months. Previous studies examined patients with diabetes. The drug works by targeting the same GLP-1 receptors as Blockbuster weight-loss jabs Ozempic, Wegovy and Mounjaro, which suppress appetite and make users fill fuller for longer. Lilly has not yet decided how much the drug will cost but it is easier to produce and transport that injections so is likely to be a cheaper option. The pill can be stored at room temperature and taken at any time of day, with or without food. It is seen as a new tool in the nation's fight against obesity and is likely to appeal to a wider audience who are uncomfortable with injecting themselves. The 72-week study involved 3,127 adults who were obese or were overweight and had a weight-related medical problem. Participants were given either a placebo or one of three possible doses of orforglipron. All three doses delivered 'clinically meaningful weight loss' but those taking the highest dose of 36mg lost an average of 27lbs (12.4kg), or 12.4 per cent of their body weight, over the study period. Almost six in ten patients (59.6 per cent) in the highest dose group lost at least 10 per cent of their body weight and four in ten (39.6 per cent) lost at least 15 per cent. Those in the placebo group lost an average of just 0.9 per cent of their body weight over the course of the study, known as ATTAIN-1. Researchers say it demonstrates the tablet has 'significant efficacy' and a safety and tolerability profile consistent with fat jabs. Lilly said it is making 'substantial investments to meet anticipated demand at launch'. Dr Kenneth Custer, executive vice president and president of Lilly Cardiometabolic Health, said: 'Obesity is one of the most pressing global health challenges of our time, driving global chronic disease burden and impacting more than one billion people worldwide. 'With orforglipron, we're working to transform obesity care by introducing a potential once-daily oral therapy that could support early intervention and long-term disease management, while offering a convenient alternative to injectable treatments. 'With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need.' Side effects on the tablet were similar to the weight-loss injections. The most commonly reported adverse events were gastrointestinal-related and generally mild-to-moderate in severity. Some 33.7 per cent of participants on the highest dose reported nausea, 25.4 per cent constipation and 23.1 per cent diahorrea. One in ten (10.3 per cent) of those on the highest dose discontinued treatment due to adverse events. The detailed ATTAIN-1 results will be presented next month at the European Association for the Study of Diabetes Annual Meeting and published in a peer-reviewed journal. Previous studies found people injected with semaglutide, the active ingredient in Wegovy and Ozempic, lost 14 per cent of their body weight over 72 weeks. And those taking tirzepatide, known as Mounjaro or the 'king kong' of weight-loss jabs, lost 20 per cent of their body weight over the the same period. Two in three adults in Britain are obese or overweight and more than 5million people have type-2 diabetes, which is linked to poor lifestyles. Estimates suggest one in ten women already take weight loss jabs. GLP-1 injections suffered global shortages after celebrity users sparked a surge in popularity and the NHS has warned people against buying them from unauthorised sources.
